Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 1, 2007, Pages 35-42

  Ferderbar, S ^a   Pereira, E C ^a   Apolinario E ^a   Bertolami, M C ^b   Faludi, A ^b   Monte, O ^c   Calliari, L E ^c   Sales, J E ^c   Gagliardi, A R ^d   Abdalla, D S P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^d Department of Neurology   (Brazil)

Author keywords

Insulin; Lipid peroxidation; Oral hypoglycemic drugs; Oxysterols; Statins

Indexed keywords

25 HYDROXYCHOLESTEROL; 3 NITROTYROSINE; 7 OXOCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ATORVASTATIN; BIOLOGICAL MARKER; CAPTOPRIL; CHOLESTANETRIOL; CHOLESTEROL; CHOLESTEROL 5ALPHA,6ALPHA OXIDE; CHOLESTEROL 5BETA,6BETA OXIDE; CHOLESTEROL OXIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FLUINDOSTATIN; GLIBENCLAMIDE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SIMVASTATIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LIPID OXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CHILD; CHOLESTANOLS; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYDROXYCHOLESTEROLS; HYPOGLYCEMIC AGENTS; INSULIN; KETOCHOLESTEROLS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 33846551823     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.645     Document Type: Article

References (39)

1. Davi G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005; 7: 256-268.
2. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 599-622.
3. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metub Res Rev 2001; 17: 189-212.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
5. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999; 142: 1-28.
6. Leonarduzzi G, Sottero B, Poli G. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). J Nutr Biochem 2002; 13: 700-710.
7. Katsumi Y, Hayashi T, Oyanagi C, et al. Glucose metabolism in the rat frontal cortex recovered without the recovery of choline acetyltransferase activity after lesioning of the nucleus basalis magnocellularis. Neurosci Lett 2000; 280: 9-12.
8. Halliwell B, Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett 1987; 213: 9-14.
9. Knight JA, Pieper RK, McClellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem 1988; 34: 2433-2438.
10. Hughes H, Smith CV, Tsokos-Kuhn JO, Mitchell JR. Quantitation of lipid peroxidation products by gas chromatography-mass spectrometry. Anal Biochem 1986; 152: 107-112.
11. Morrow JD, Roberts LJ II. Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress. Free Radic Biol Med 1991; 10: 195-200.
12. van Kuijk FJ, Thomas DW, Stephens RJ, Dratz EA. Gas chromatography-mass spectrometry method for determination of phospholipid peroxides; II. Transesterification to form pentafluorobenzyl esters and detection with picogram sensitivity. J Free Radic Biol Med 1985; 1: 387-393.
13. Sevanian A, Mead JF, Stein RA. Epoxides as products of lipid autoxidation in rat lungs. Lipids 1979; 14: 634-643.
14. Sevanian A, Seraglia R, Traldi P, Rossato P, Ursini F, Hodis H. Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. Free Radic Biol Med 1994; 17: 397-409.
15. Mol MJ, de Rijke YB, Demacker PN, Stalenhoef AF. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 1997; 129: 169-176.
16. Matsui H, Okumura K, Mukawa H, Hibino M, Toki Y, Ito T. Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy. Can J Cardiol 1997; 13:373-379.
17. Dyer RG, Stewart MW, Mitcheson J, George K, Alberti MM, Laker MF. 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease. Clin Chim Acta 1997; 260: 1-13.
18. Inouye M, Mio T, Sumino K. Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients. Metabolism 1999;48:205-209.
19. Deckert V, Brunet A, Lantoine F, et al. Inhibition by cholesterol oxides of NO release from human vascular enclothelial cells. Arterioscler Thromb Vasc Biol 1998; 18: 1054-1060.
20. Mabley JG, Soriano FG. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction. Carr Vasc Pharmacol 2005; 3: 247-252.
21. Tanaka Y, Uchino H, Shimizu T, et al. Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats. Eur J Pharmacol 1999;376:17-22.
22. Gargiulo P, Caccese D, Pignatelli P, et al. Metformin decreases platelet superoxide anion production in diabetic patients. Diabetes Metab Res Rev 2002; 18: 156-159.
23. Kanigur-Sultuybek G, Guven M, Onaran I, Tezcan V, Cenani A, Hatemi H. The effect of metformin on insulin receptors and lipid peroxidation in alloxan and streptozotocin induced diabetes. J Basic Clin Physiol Pharmacol 1995; 6: 271-280.
24. Pavlovic D, Kocic R, Kocic G, et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab 2000; 2: 251-256.
25. Munzel T, Keaney JF Jr. Are ACE inhibitors a "magic bullet" against oxidative stress? Circulation 2001; 104: 1571-1574.
26. Delbosc S, Morena M, Djouad F, Ledoucen C, Descomps B, Cristol JP. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J Cardiovasc Phormacol 2002; 40: 611-617.
27. Tomas M, Senti M, Garcia-Faria F, et al. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2000; 20: 2113-2119.
28. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998;273:24266-24271.
29. Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol 1999; 33:234-241.
30. Franzoni F, Quinones-Galvan A, Regoli F, Ferrannini E, Galetta F. A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol 2003; 90: 317-321.
31. Kyselova P, Zourek M, Rusavy Z, Trefil L, Racek J. Hyperinsulinemia and oxidative stress. Physiol Res 2002; 51: 591-595.
32. Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 1995; 18: 646-653.
33. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Estimation of lipoperoxidative damage and antioxidant status in diabetic children: Relationship with individual antioxidants. Free Radic Res 2005; 39: 933-942.
34. Chiarelli F, Santilli F, Sabatino G, et al. Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type I diabetes and early microangiopathy. Pediatr Res 2004; 56: 720-725.
35. Ceriello A, Morocutti A, Mercuri F, et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 2000; 49: 2170-2177.
36. Chiarelli F, Cipollone F, Mohn A, et al. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 2002; 25: 1829-1834.
37. Yoshioka N, Adachi J, Ueno, Y, Yoshida K. Oxysterols increase in diabetic rats. Free Radic Res 2005; 39: 299-304.
38. Murakami H, Tamasawa N, Matsui J, Yasujima M, Suda T. Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia. Lipids 2000; 35: 333-338.
39. Evans JL, Maddux BA, Goldfine ID. The mojecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040-1052.